Basel Medical Group Ltd BMGL
Annual
Quarterly
FY2025 · ended Jun 30, 2025 · Revenue $8.90M · Filed Mar 13, 2026
Basel Medical Group Ltd (BMGL) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Jun 30, 2025, it reported revenue of $8.9 million and a net loss of $8.4 million. Free cash flow was -$3.6 million. As of Jun 30, 2025 it held $2.4 million in cash and investments and $7.9 million in total debt.
Revenue
$8.90M
Net income
$-8.36M
Operating cash flow
$-3.18M
Free cash flow
$-3.62M
EPS
$-0.45
Dividend per share
None
Shares outstanding
1.58M
-91.6% vs prior year
Net cash
$-5.54M
FY 2025
Operating margin
—
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- BMGL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Virgin Islands, British
- Headquarters
- Singapore, Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2004489
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Jun 30, 2025 |
|---|---|
| Revenue | $8.9M |
| Net income | -$8.4M |
| Diluted EPS | -$0.45 |
| Operating cash flow | -$3.2M |
| Free cash flow | -$3.6M |
| Total assets | $14.7M |
| Total liabilities | $10.4M |
| Stockholders' equity | $4.3M |
| Cash and investments | $2.4M |
| Total debt | $7.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
All 84 Basel Medical Group Ltd SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.